Katherine Aird
University of Pittsburgh
H-index: 30
North America-United States
Top articles of Katherine Aird
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15 | Gynecologic Oncology | Caroline Chang Ya-Yun Cheng Shriya Kamlapurkar Sierra White Priscilla W Tang | 2024/6/1 |
Deoxyuridine-rich cytoplasmic DNA antagonizes STING-dependent innate immune responses and sensitizes resistant tumors to anti-PD-L1 therapy | bioRxiv | Pinakin Pandya Frank P Vendetti Joseph A El-Ghoubaira Sudipta Pathak Joshua J Deppas | 2024 |
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression | Cancer Research Communications | Naveen Kumar Tangudu Raquel Buj Hui Wang Jiefei Wang Aidan R Cole | 2024/4/16 |
αKG-mediated carnitine synthesis promotes homologous recombination via histone acetylation | bioRxiv | Apoorva Uboveja Zhentai Huang Raquel Buj Amandine Amalric Hui Wang | 2024/2/7 |
CASC4/GOLM2 drives high grade serous carcinoma anoikis resistance through the recycling of EGFR | Cancer Gene Therapy | Jaidev Bapat Tomomi M Yamamoto Elizabeth R Woodruff Lubna Qamar Railey G Mikeska | 2024/2 |
Abstract IA022: Uracil DNA glycosylase activity limits deoxyuridine contamination in genomic DNA and is essential for the type-1 interferon response in cells treated with ATR … | Cancer Research | Pinakin Pandya Frank P Vendetti Joseph A Ghoubaira Sudipta Pathak Joshua J Deppas | 2024/1/9 |
Mitochondrial ROS Triggers KIN Pathogenesis in FAN1-Deficient Kidneys | Antioxidants | Merlin Airik Haley Arbore Elizabeth Childs Amy B Huynh Yu Leng Phua | 2023/4/8 |
Senescence and Immunotherapy: Redundant Immunomodulatory Pathways Promote Resistance | Cancer Immunology Research | Steffi Oesterreich Katherine M Aird | 2023/4/3 |
Paracrine effects of the senescence-associated secretory phenotype decrease cancer cell adhesion | bioRxiv | Aidan R Cole Raquel Buj Amal Taher Elhaw Apoorva Uboveja Naveen Kumar Tangudu | 2023 |
ATR promotes mTORC1 activation via de novo cholesterol synthesis in p16-low cancer cells | bioRxiv | Naveen Kumar Tangudu Zhentai Huang Richard Fang Raquel Buj Apoorva Uboveja | 2023/10/27 |
Alternative splice variants of the mitochondrial fission protein DNM1L/Drp1 regulate mitochondrial dynamics and tumor progression in ovarian cancer | bioRxiv | Zaineb Javed Dong Hui Shin Weihua Pan Sierra R White Yeon Soo Kim | 2023/9/20 |
Tumor-Associated Macrophages Expand Chemoresistant, Ovarian Cancer Stem-Like Cells | bioRxiv | Allison C Sharrow Madeline Ho Aakriti Dua Raquel Buj Kim RM Blenman | 2023/7/19 |
The senescence-associated secretory phenotype in ovarian cancer dissemination | Jacob P Veenstra Lucas Felipe Fernandes Bittencourt Katherine M Aird | 2022/7/1 | |
53BP1: guarding the genome with a novel liquid weapon | Communications Biology | Naveen Kumar Tangudu Katherine M Aird | 2022/5/10 |
Thymidine rescues ATR kinase inhibition induced deoxyuridine contamination in genomic DNA, cell death, and Type 1 interferon expression | bioRxiv | Norie Sugitani Frank P Vendetti Andrew J Cipriano Pinakin Pandya Joshua J Deppas | 2022/2/26 |
ATM inhibition drives metabolic adaptation via induction of macropinocytosis | Journal of Cell Biology | Zhentai Huang Chi-Wei Chen Raquel Buj Naveen Kumar Tangudu Richard S Fang | 2022/11/18 |
Exploiting Metabolic Vulnerabilities to Target Multidrug-Resistant Ovarian Cancer | Katherine M Aird | 2022/10/1 | |
Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expression | Cell reports | Norie Sugitani Frank P Vendetti Andrew J Cipriano Pinakin Pandya Joshua J Deppas | 2022/9/20 |
Loss of p16: a bouncer of the immunological surveillance? | Kelly E Leon Naveen Kumar Tangudu Katherine M Aird Raquel Buj | 2021/4/2 | |
Suppression of p16 alleviates the senescence-associated secretory phenotype | Raquel Buj Kelly E Leon Marlyn A Anguelov Katherine M Aird | 2021/2/2 |
